MSB 4.52% 95.0¢ mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-407

  1. 12,319 Posts.
    lightbulb Created with Sketch. 1103
    Hi
    Could have two approvals this year.
    John thought that the FDA would require another trial .
    Glad he was wrong.

    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.